About 300 reports

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide, accounting for 0.6 million deaths in 2018, in the US alone. The World Health Organization has estimated the number of new cancer cases, reported across the globe, to rise by 70% over the next 20 years. Conventional treatment options, such as...

  • Therapy
  • Targeted Therapy
  • Cancer
  • World
  • United States

Abstract: - Global Liver Diseases Treatment Market to Reach $27.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Liver Diseases Treatment estimated at US$13.6 Billion in the year 2020, is projected to reach a revised size of US$27.2 Billion by 2027, growing at a CAGR of 10.4% over the analysis period...

  • Digestive System Disorder
  • Targeted Therapy
  • World
  • China
  • United States

Abstract: - The global market for Cancer Therapies is projected to reach US$220.5 billion by 2025, driven by the rise in cancer prevalence to epidemic proportions and the still ongoing search to find effective treatments for the disease. Despite decades of research costing billions of dollars, a cure for cancer still remains...

  • Oncology
  • Targeted Therapy
  • World

TARGETED THERAPY

  • Renal Cancer
  • Cancer
  • Diagnostics
  • Targeted Therapy
  • APAC
  • Europe
  • Africa
  • King County
  • Smoking Prevalence
  • Cause-Specific Mortality Rate

Abstract: - Global Sarcoma Drugs Market to Reach $1.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Sarcoma Drugs estimated at US$871.4 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 7.1% over the period 2020-2027. Targeted Therapy,...

  • Cancer
  • Targeted Therapy
  • Chemotherapy
  • World
  • China
  • United States

Abstract: - Global Amyloidosis Treatment Market to Reach $6.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Amyloidosis Treatment estimated at US$4.3 Billion in the year 2020, is projected to reach a revised size of US$6.5 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027....

  • Endocrine Disease
  • Targeted Therapy
  • World
  • China
  • United States

Targeted Therapy Drug

  • Ovarian Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Industrial Production
  • Labour Force

Targeted Therapy Drug

  • Breast Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Industrial Production
  • Labour Force

Report Description This report examines the global anticancer drugs market for the period 2013–2026. The primary objective of the report is to offer insights into market opportunities for anticancer drugs and developments in the anticancer drugs market. The global anticancer drugs market is expected to yield impressive...

  • Oncology
  • Targeted Therapy
  • Cancer
  • In-Store Retail
  • World
  • Cancer Mortality
  • Biologics Penetration Rate

This study explores the global immuno-oncology (I-O) market’s evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune system is the...

  • Infectious Disease
  • Targeted Therapy
  • Cancer Immunotherapy
  • Pharmaceutical
  • Gene Therapy
  • Monoclonal Antibody
  • Cell Therapy
  • World

Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy & Targeted Therapies, and Others), Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, and Panuveitis), and Distribution Channel (Hospital Pharmacy, Drug Store & Retail Pharmacy, and Online Providers): Global Opportunity...

  • Therapy
  • Antiseptics
  • Targeted Therapy
  • Analgesic
  • Pharmacy
  • World
  • APAC
  • Europe

Major players in the thyroid cancer drugs market are Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., and Jerome Stevens Pharmaceuticals Inc. The global thyroid cancer drugs market is expected to grow from $0.4 billion in 2020 to $0.47 billion in 2021 at a compound annual...

  • Oncology
  • Targeted Therapy
  • World
  • United States
  • Drug Approval

The Global Cervical Cancer Treatment Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include increasing R&D expenditure in oncologic diseases, improvement of systemic chemotherapy and rise in conservative treatment in early stage disease. Based...

  • Hormone
  • Chemotherapy
  • Cancer
  • Targeted Therapy
  • Cervical Cancer
  • World

Report Scope: The scope of this report is broad and covers category, source and applications of Tumor-specific Antigen.The market has been segmented by source into coding region and Non-Coding region. Revenue forecasts from 2017 to 2023 are given for each segment and regional market with estimated value derived...

  • Monoclonal Antibody
  • World

■ Market demand for biopharmaceuticals is increasing with the rising desire to circumvent the side effects associated with some small-molecule therapeutics and invasive surgical treatments.

  • Biopharmaceutical
  • Monoclonal Antibody
  • Infectious Disease
  • Vaccine
  • Protein Therapy
  • Biotech Vaccine
  • APAC
  • Indiana
  • Health Expenditure
  • Drug Approval

Targeted Therapy Drug

  • Ovarian Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Labour Force
  • Industrial Production

Targeted Therapy Drug Import

  • Breast Cancer
  • Chemotherapy
  • Targeted Therapy
  • Cancer Hormonal Therapy
  • China
  • Labour Force
  • Industrial Production

Global Gene Panel Market: About this market This gene panel market analysis considers sales from small panel testing and large panel testing products. Our study also finds the sales of gene panels in Asia, Europe, North America, and ROW. In 2019, the small panel testing segment had a significant market share, and this...

  • Targeted Therapy
  • Oncology
  • Genetic Testing
  • World

## Pipeline Holds Potential for the Approval of More Targeted Therapies

  • Therapy
  • Targeted Therapy
  • Epidemiology
  • World
  • Prescription Drug Sales
  • Biologics Approval

The Global Auto Injectors Market is poised to grow strong during the forecast period 2017 to 2027.. Some of the prominent trends that the market is growing prevalence of targeted therapies and favorable reimbursements and government support. Based on Product type, the market is categorized into prefilled...

  • Arthritis
  • Targeted Therapy
  • Cardiovascular Disease
  • Neurological Disorder
  • Home Healthcare
  • Pain Relief
  • Diabetes
  • Autoimmune Disease
  • Pharmacy
  • World

a. Targeted Therapy

  • Therapy
  • Targeted Therapy
  • Drug Development
  • World
  • United States
  • Drug Approval
  • Mortality Rate

“PARP Inhibitors– Pipeline Insight, 2020,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in PARP Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Targeted Therapy
  • World
  • China

United States North America World Pharmaceutical Registrations Cancer Mortality Cause-Specific Mortality Rate Drug Approval Monoclonal Antibody Hospital Pathology Therapy Pharmaceutical Healthcare Immunotherapy Targeted Therapy Chronic Disease

  • Pathology
  • Pharmaceutical
  • Therapy
  • Healthcare
  • Drug Development
  • Monoclonal Antibody
  • Protein Therapy
  • Infectious Disease
  • World
  • United Kingdom
  • Sweden
  • Drug Approval
  • Pharmaceutical Registrations

University reported that small molecule inhibitors, or monoclonal antibodies targeting CD## in murine tumor models, that targeted CD## therapy was an important alternative and realistic approach to effective control of tumor growth.

  • Oncology
  • Monoclonal Antibody
  • Ovarian Cancer
  • Pharmaceutical
  • World

“Global Anaplastic Lymphoma Kinase ALK Inhibitors Market & Clinical Trials Insight 2026” Report Highlights: • Global ALK Inhibitors Market Opportunity: > USD 5 Billion • US Dominates Global ALK Inhibitors Market Sales: >30% • Approved ALK Inhibitors: 5 Drugs • Global & Regional ALK Inhibitors Market Sales Insights...

  • Targeted Therapy
  • World

Global Anti-CD20 Monoclonal Antibodies (mABs) Market: About this market This anti-CD20 monoclonal antibodies (mABs) market analysis considers sales from oncology, neurology, and immunology. Our analysis also considers the sales of anti-CD20 monoclonal antibodies (mABs) in Asia, Europe, North America, and ROW. In 2018,...

  • Monoclonal Antibody
  • World

Regeneron Pharmaceuticals, Inc. announced the results of the trial-the first placebo-controlled study investigating IL-## targeted therapy in prevention of gout flares-show rilonacept to be generally well tolerated with no serious infections or treatment-related serious adverse events reported.

  • Therapy
  • Monoclonal Antibody
  • Drug Development
  • Protein Therapy
  • Infectious Disease
  • World
  • United Kingdom
  • Sweden
  • Pharmaceutical Registrations
  • Drug Approval

The Asia Pacific Uveitis Treatment Market would witness market growth of 6.7% CAGR during the forecast period (2019-2025). Anti-inflammatory medications are available in the form of eye drops, pills, or injection medicine. Anti-inflammatory medication eye drops may not penetrate well to the back of the eye, so this form of treatment...

  • Antiseptics
  • Targeted Therapy
  • Analgesic
  • Immunotherapy
  • In-Store Retail
  • Hormone
  • APAC

Global Phosphoinositide 3-Kinase (PI3K) inhibitors Market: About this market Phosphoinositide 3-kinase (PI3K) inhibitors restricts PI3K enzymes and help in controlling cancer. This phosphoinositide 3-kinase inhibitors market analysis considers sales from chronic lymphocytic leukemia (CLL), follicular lymphoma (FL),...

  • Targeted Therapy
  • World
  • Cancer Incidence

“DARATUMUMAB- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for AL Amyloidosis in 7 Major Markets. A detailed picture of the DARATUMUMAB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study...

  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure